MétaCan
Menu
← Back to cohort
Record W4411678460 · doi:10.1101/2025.06.25.25330260

Causal machine learning for assessing the effectiveness of off-label use of amiodarone in new-onset atrial fibrillation

2025· preprint· en· W4411678460 on OpenAlexaff
Simon Schallmoser, Jonas Schweisthal, Alexander von Ehr, Hamid Ghanbari, Fridtjof Schiefenhövel, Thomas S. Valley, Jenna Wiens, Stefan Feuerriegel

Bibliographic record

VenuemedRxiv · 2025
Typepreprint
Languageen
FieldMedicine
TopicAtrial Fibrillation Management and Outcomes
Canadian institutionsArtificial Intelligence in Medicine (Canada)
FundersSchweizerischer Nationalfonds zur Förderung der Wissenschaftlichen ForschungNational Science Foundation
KeywordsAmiodaroneAtrial fibrillationMedicineInternal medicineCardiologyComputer scienceArtificial intelligenceMachine learningPsychology

Abstract

fetched live from OpenAlex

Abstract Off-label drug use, i.e., uses of a drug that differ from what regulatory authorities have approved, is common, occurring overall in up to 36% of prescriptions. Yet, the effectiveness across different patient subgroups is often poorly understood. In this study, we demonstrate how one can use causal machine learning (ML) together with real-world data to identify which patient groups are most likely to benefit from off-label use. Specifically, we assessed the effectiveness of off-label use of amiodarone in patients with new-onset atrial fibrillation (NOAF). NOAF can often lead to hemodynamic instability and rapid ventricular response, so that hemodynamic stability should be restored. We developed a causal ML model to predict individualized treatment effects (ITEs) of off-label amiodarone use on the probability of returning to hemodynamic stability. We used real-world data from the U.S. to develop the causal ML model and externally evaluated that model on real-world data from the Netherlands. Our predicted ITEs show that 44.8% (95% confidence interval [CI]: 38.4% to 51.0%) of patients benefit from off-label use of amiodarone with large heterogeneity: amiodarone is predicted to increase the probability of restoring hemodynamic stability by a mean of 0.5 percentage points (pp), with an interquartile range (IQR) of − 1.1 pp to 1.0 pp, in the external dataset from the Netherlands. Using these ITEs, we defined a personalized treatment rule, which could increase the number of patients achieving hemodynamic stability by 4.4% (95% CI: 1.0% to 7.8%) compared to current practice. Additionally, we studied which biomarkers are predictive of treatment effect heterogeneity and found that patients with higher blood pressure may benefit most from off-label use of amiodarone. Altogether, our study shows the potential of causal ML together with real-world data in identifying patients who benefit from off-label drug use.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.026
metaresearch head score (Gemma)0.083
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Simulation or modeling · Consensus signal: Simulation or modeling
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.026
Threshold uncertainty score0.139

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0260.083
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0020.003
Bibliometrics0.0030.001
Science and technology studies0.0000.001
Scholarly communication0.0020.001
Open science0.0010.001
Research integrity0.0020.003
Insufficient payload (model declined to judge)0.0040.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.096
GPT teacher head0.385
Teacher spread0.289 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designSimulation or modeling
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes1
Has abstractyes

Explore more

Same venuemedRxiv→Same topicAtrial Fibrillation Management and Outcomes→French-language works237,207→